Holbæk Sygehus

Medicin og biovidenskab

1. Denmark 100%
2. Randomized Controlled Trials 85%
3. Systematic Reviews 76%
4. Cohort Studies 75%
5. Pediatric Obesity 67%
6. Meta-Analysis 62%
7. Mortality 59%
8. Child 56%
9. Obesity 52%
10. Blood Pressure 46%
11. Population 45%
12. Confidence Intervals 42%
13. Type 2 Diabetes Mellitus 39%
14. Registries 37%
15. Osteoporosis 37%
16. Cardiovascular Diseases 36%
17. Therapeutics 35%
18. Health 34%
19. Overweight 33%
20. Body Mass Index 32%
21. Intensive Care Units 32%
22. Hypertension 31%
23. Placebos 31%
24. Hip Fractures 29%
25. Quality of Life 29%
26. Exercise 28%
27. Odds Ratio 27%
28. Occupational Groups 24%
29. Observational Studies 24%
30. Osteoporotic Fractures 22%
31. Diphosphonates 21%
32. Pregnancy 21%
33. Critical Care 20%
34. Pain 19%
35. Mothers 18%
36. Nurses 18%
37. Serum 18%
38. Atrial Fibrillation 18%
39. Coronavirus 17%
40. Incidence 17%
41. Heart Failure 17%
42. Myocardial Ischemia 17%
43. Workplace 16%
44. Fasting 16%
45. Comorbidity 16%
46. Fats 16%
47. Insulin Resistance 16%
48. Guidelines 16%
49. Early Warning Score 15%
50. Cross-Sectional Studies 15%
51. Glucose 15%
52. Prospective Studies 15%
53. Uterine Rupture 15%
54. Databases 15%
55. Myocardial Infarction 15%
56. Biomarkers 15%
57. Parturition 15%
58. Low Back Pain 14%
59. Stroke 14%
60. Safety 14%
61. First Pregnancy Trimester 13%
62. Critical Illness 13%
63. Dialysis 13%
64. Weight Loss 13%
65. Morbidity 13%
66. Leisure Activities 13%
67. Polycystic Ovary Syndrome 13%
68. Cardiac Rehabilitation 13%
69. Weights and Measures 13%
70. Delivery of Health Care 13%
71. Left Ventricular Hypertrophy 13%
72. Gestational Age 13%
73. Vitamin D 12%
74. Pediatrics 12%
75. Elderly 12%
76. Delirium 12%
77. Hospital Emergency Service 12%
78. Multicenter Studies 12%
79. SARS Virus 12%
80. Hospitalization 12%
81. Renal Replacement Therapy 12%
82. Leptin 12%
83. Data Analysis 12%
84. Bone Density 11%
85. Hemorrhage 11%
86. Pregnant Women 11%
87. Antihypertensive Agents 11%
88. Pregnancy Outcome 11%
89. Urokinase Plasminogen Activator Receptors 10%
90. Bone and Bones 10%
91. Adiponectin 10%
92. Clinical Trials 10%
93. Reference Values 10%
94. Pharmaceutical Preparations 10%
95. Carotid-Femoral Pulse Wave Velocity 10%
96. Logistic Models 10%
97. Hip 10%
98. Equipment and Supplies 10%
99. Case-Control Studies 10%
100. Primary Health Care 10%